Clinical aspects of iron use in the anemia of kidney disease.
Hörl
Walter H
WH
Division of Nephrology and Dialysis, Department of Medicine III, Währinger Gürtel 18-20 A-1090 Vienna, Austria. walter.hoerl@meduniwien.ac.at
D000328:Adult; D018798:Anemia, Iron-Deficiency / Q000188:drug therapy / Q000209:etiology*; D002648:Child; D005293:Ferritins / Q000097:blood; D005296:Ferrous Compounds / Q000627:therapeutic use; D006801:Humans; D007501:Iron / Q000009:adverse effects / Q000378:metabolism* / Q000627:therapeutic use*; D019190:Iron Overload / Q000517:prevention & control; D007668:Kidney / Q000502:physiology; D007674:Kidney Diseases / Q000378:metabolism*; D007676:Kidney Failure, Chronic / Q000378:metabolism*; D012016:Reference Values
D005296:Ferrous Compounds; C020748:ferrous sulfate; D005293:Ferritins; D007501:Iron